The Food and Drug Administration has approved the Pfizer COVID-19 vaccine, paving way for close to three million highly-vulnerable Americans to receive the vaccine next week....
The Pfizer and BioNTech COVID-19 vaccine is now clinically safe and would be made available for use by next week with priority given to the most...
Pfizer is on track to deliver up to 50 million doses in 2020 and about 1.3 billion doses in 2021. The duo of Pfizer Inc (NYSE:...
The Moderna vaccine trial involved about 30,000 participants and the interim analysis for the vaccine was based on 95 infections among the trial participants The stock...
Although the vaccine by AstraZeneca has not been globally approved, it was used in the treatment of U.S. President Donald Trump. AstraZeneca plc (NASDAQ: AZN) stocks...
The start of the review process of the BioNTech-Pfizer vaccine has triggered investors to bet more on BNTX stock. The European Union’s European Medicines Agency (EMA)...
AstraZeneca’s clinical trials for the vaccine were halted in July after one of the participants complained of neurological disorder. Foremost COVID-19 vaccine pharmaceutical firm AstraZeneca Plc...
As of midnight Eastern, Dow Jones Industrial Average futures were up around 300 points, or 1%, while S&P 500 futures jumped 1.2% and Nasdaq-100 futures gained 1.5%. ...
In partnership with U.K.’s Oxford University, AstraZeneca said that it will resume the phase three clinical trial for its COVID-19 vaccine contender AZD1222 since it got...
The Phase 3 trial started on August 31 and enrolled about 30,000 participants at 80 locations. Now it is unclear how long the clinical hold will...
Neueste Kommentare